Want to see ELOX full AI Analyst Report?
Eloxx Pharmaceuticals (ELOX) Income Statement
Eloxx Pharmaceuticals Income Statement
Last quarter (Q2 2026), Eloxx Pharmaceuticals's total revenue was $0.00. In Q2, Eloxx Pharmaceuticals's net income was $-4.50M. See Eloxx Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 0.00 | $ 6.36M | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 6.36M | $ 0.00 | $ -695.00K | $ -960.00K | |
| $ 6.44M | $ 8.83M | $ 17.29M | $ 33.72M | $ 41.39M | |
| Depreciation and Amortization | $ 0.00 | $ 164.00K | $ 809.00K | $ 695.00K | $ 960.00K |
| $ -4.95M | $ -1.83M | $ -15.09M | $ -33.50M | $ -64.51M | |
| $ -6.44M | $ -2.47M | $ -17.29M | $ -34.42M | $ -42.35M | |
| $ 443.00K | $ -675.00K | $ 234.00K | $ -1.72M | $ -24.38M | |
| $ -6.00M | $ -3.14M | $ -17.05M | $ -36.14M | $ -66.73M | |
| $ -6.00M | $ -3.14M | $ -17.05M | $ -36.06M | $ -66.73M | |
| Per Share Metrics | |||||
| Basic EPS | $ -5.34 | $ -9.24 | $ -72.93 | $ -183.13 | $ -419.65 |
| Diluted EPS | $ -5.34 | $ -9.24 | $ -72.93 | $ -183.13 | $ -419.65 |
| Weighted Average Shares Outstanding | 1.12M | 341.71K | 233.69K | 196.94K | 159.01K |
| Weighted Average Shares Outstanding (Diluted) | 1.12M | 341.71K | 233.69K | 196.94K | 159.01K |
Currency in USD
